iShares Genomics Immunology and Healthcare ETF
IDNA
IDNA
37 hedge funds and large institutions have $30.1M invested in iShares Genomics Immunology and Healthcare ETF in 2020 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
13.45% less ownership
Funds ownership: 34.59% → 21.14% (-13%)
Holders
37
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$9.47M | |
| 2 | +$1.33M | |
| 3 | +$1.17M | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1.04M |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
+$1.03M |
Top Sellers
| 1 | -$6.28M | |
| 2 | -$4.03M | |
| 3 | -$1.68M | |
| 4 |
AIC
Archer Investment Corporation
Carmel,
Indiana
|
-$75.9K |